Centogene Share Holder Equity 2019-2023 | CNTG

Centogene share holder equity from 2019 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
Centogene Annual Share Holder Equity
(Millions of US $)
2023 $-27
2022 $8
2021 $33
2020 $75
2019 $66
2018 $31
Centogene Quarterly Share Holder Equity
(Millions of US $)
2022-06-30 $22
2022-03-31 $37
2021-12-31 $33
2021-09-30 $44
2021-06-30 $69
2021-03-31 $76
2020-12-31 $75
2020-09-30 $69
2020-06-30 $46
2020-03-31 $57
2019-09-30 $12
2019-06-30 $17
2018-12-31 $31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.000B $0.053B
Centogene is a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The Company?s goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using their knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $37.403B 20.54
Inspire Medical Systems (INSP) United States $4.527B 0.00
Hims & Hers Health (HIMS) United States $3.772B 0.00
Axonics (AXNX) United States $3.448B 0.00
Olink Holding AB (publ) (OLK) Sweden $2.988B 0.00
10x Genomics (TXG) United States $2.854B 0.00
IRhythm Technologies (IRTC) United States $2.846B 0.00
Azenta (AZTA) United States $2.779B 156.21
Enovis (ENOV) United States $2.764B 20.48
Privia Health (PRVA) United States $1.927B 107.67
Schrodinger (SDGR) United States $1.602B 0.00
Omnicell (OMCL) United States $1.465B 50.65
Phreesia (PHR) United States $1.354B 0.00
Standard BioTools (LAB) United States $0.749B 0.00
Definitive Healthcare (DH) United States $0.666B 0.00
Fulgent Genetics (FLGT) United States $0.641B 0.00
Talkspace (TALK) United States $0.467B 0.00
Clover Health Investments (CLOV) United States $0.460B 0.00
Health Catalyst (HCAT) United States $0.400B 0.00
Pulmonx (LUNG) United States $0.341B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.303B 0.00
Butterfly Network (BFLY) United States $0.228B 0.00
Outset Medical (OM) United States $0.190B 0.00
P3 Health Partners (PIII) United States $0.168B 0.00
American Well (AMWL) United States $0.142B 0.00
TruBridge (TBRG) United States $0.137B 7.38
111 (YI) China $0.108B 0.00
MSP Recovery (LIFW) United States $0.101B 0.00
SHL Telemedicine (SHLT) Israel $0.083B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.062B 0.00
Augmedix (AUGX) United States $0.059B 0.00
EUDA Health Holdings (EUDA) Singapore $0.058B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.057B 0.00
Zepp Health (ZEPP) China $0.050B 0.00
CareCloud (CCLD) United States $0.047B 0.00
Movano (MOVE) United States $0.045B 0.00
Akili (AKLI) United States $0.032B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.030B 0.00
Bullfrog AI Holdings (BFRG) United States $0.024B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
Cue Health (HLTH) United States $0.019B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Biotricity (BTCY) United States $0.010B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Syra Health (SYRA) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00